MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Pharmaceutical Executive
June 1, 2011
2011 Dealmakers Outlook With Yankee stadium as the backdrop, Pharm Exec convened on March 29 its annual panel of eight business development experts to crack the bat on best practice in licensing for the year ahead. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2005
Jeffrey D. Abbey
Considering Intangibles Biotech partnerships among scientists, academic institutions, and pharma companies provide many challenges, including identifying the right partners, developing strong relationships to overcome hurdles, and dealing with cultural differences in an increasingly global market. mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2012
2012 Dealmakers Outlook With Yankee Stadium as the backdrop, Pharm Exec convened on its annual panel of heavy hitters in business development to crack the bat on best practices in licensing and for the year ahead. mark for My Articles similar articles
Chemistry World
August 23, 2012
Simon Campbell
Protecting patients at all costs A new funding model is urgently required to deliver innovative medicines that meet the medical needs of the 21st century and contribute to economic growth. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2011
The San Diego Story San DIego works as a locus for risky investments in the big ideas that lead to biotech breakthroughs mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2007
Waseem Noor
Toolkit: How To Be a Better Partner Big pharmas and little biotechs have been getting hitched for years. Now it's time to add a little innovation to the relationship. Three new rules will keep the game exciting. mark for My Articles similar articles
Pharmaceutical Executive
July 10, 2014
William Looney
Pharm Exec's 2014 Dealmakers Outlook As the pacing picks up around dealmaking as the alternative to organic growth, Pharm Exec brings together experts from big Pharma and biotech to dissect the road ahead. mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2005
Thought Leaders: Playing Field in Biotech/Pharma Partnerships Levels As infrastructure and business savvy within biotechs become increasingly sophisticated, the sector's relationship with pharma is taking on a new shape. An interview with industry veteran Lisa Drakeman on how to integrate cultures and processes and where pharma is falling short. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2010
Looking Beyond the Patent Cliff Pfizer's VP and Assistant General Counsel for Global Patents and Policy, Roy Waldron, discusses its collaborative strategy to refresh the face of IP. mark for My Articles similar articles
Entrepreneur
September 2003
David Newton
Now Showing Win partners by letting them see what you're made of -- with a "portfolio" of your patented technology. mark for My Articles similar articles
The Motley Fool
April 14, 2011
Frank Vinluan
Biogen Idec Inks Biotech Blood Products Research Deal With Amunix The exclusive, worldwide research collaboration agreement calls for both companies to jointly conduct preclinical research. mark for My Articles similar articles
HBS Working Knowledge
October 4, 2004
Loren Gary
The Profit Power of Partnerships For many top companies, revenue from alliances is growing more than 20 percent annually. What goes into a successful alliance? The critical first step is picking the right partner. mark for My Articles similar articles
Pharmaceutical Executive
April 10, 2014
Christini & Kaitin
Regional Trends in Bioinnovation Investment Can the Cambridge model be duplicated? mark for My Articles similar articles
CFO
April 1, 2011
Josh Hyatt
Grab Your Partner(s) With the economy's choppy waters calming down, companies are finding that a partnership strategy born of necessity can also be a valuable part of a growth strategy. mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2009
The Shakeout When it comes to licensing in this market, there are winners and losers. Learn the new rules of the game. mark for My Articles similar articles
Entrepreneur
April 2008
Guy Kawasaki
Tying the Knot Partnering is an art, so make sure everyone sees eye to eye with these 8 tips. mark for My Articles similar articles
Pharmaceutical Executive
July 1, 2011
Todd C. Davis
Seeing the Fire Behind the Smoke While crafting license agreements involves all of the tactical tradeoffs expected in a negotiating dynamic, one should try to pay attention to these 10 licensing pitfalls. mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2006
Paul Kidwell
Public Relations: Targeting Partners PR can facilitate business partnerships between biotechnology and pharmaceutical companies by targeting messages to key players. mark for My Articles similar articles
Pharmaceutical Executive
March 1, 2013
Henninger & Feldstein
Safeguarding the Value of Patent Assets As small biotech firms test the water in partnerships with Big Pharma, the best calling card is a well-framed strategy on intellectual property. mark for My Articles similar articles
IndustryWeek
February 1, 2009
Jill Jusko
IP Assets Deserve Their Due Diligence in M&A Transactions Companies believe that intellectual property assets will become more important to overall M&A activity in the next five years. mark for My Articles similar articles
D-Lib
December 2007
Kaufman & Ubois
Good Terms - Improving Commercial-Noncommercial Partnerships for Mass Digitization OCLC Programs and Research engaged Intelligent Television to study the partnership agreements between cultural institutions and for-profit companies for the mass digitization of books and other media. This report presents the findings of that study. mark for My Articles similar articles
Pharmaceutical Executive
November 1, 2011
Turbulent Waters: M&As 2011 The latest numbers in pharma deals reveals a sector in transition, where market volatility has sharply degraded the appetite for risk. mark for My Articles similar articles
Information Today
June 26, 2014
Thomson Reuters and Royal Philips Team Up to Protect IP The partnership is designed to protect intellectual property, business intelligence, and foster product innovation. mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2011
Thompson & Twait
High-Risks to High Reward According to Eli Lilly, managing alliances requires more than good people skills. mark for My Articles similar articles
Pharmaceutical Executive
April 1, 2012
Leading from the South India's most prominent scientist sets a new agenda for pharma in emerging markets. mark for My Articles similar articles
CIO
June 1, 2003
John Edwards
Creative Management Intellectual property asset management tools help businesses get a handle on mind-based products. mark for My Articles similar articles
Knowledge@Wharton The Benefits Are Mutual in New Wave of Biotech/Pharma Alliances The spat that erupted between pharma giant Bristol-Myers Squibb and biotech firm ImClone Systems over their partnership to develop a new cancer drug put the structure of alliances between discovery research firms and big drug makers under a microscope... mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2006
Nick Rogerson
Slow Deal Flow? 10 Quick Fixes for Getting Business Development Back on Track mark for My Articles similar articles
Registered Rep.
November 1, 2002
Jonathan Arfa
Breaking Up Is Hard to Do Brokers partner up for a variety of reasons. Some kind of contract is needed when a partnership between members of a team of brokers is formed, whether it be between a senior broker and junior colleagues or just between two seasoned brokers. Brokers should consider this contract seriously. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2010
Explaining the Drug Drought Industry needs to engage in a broader public debate on ways to rekindle the innovative engine in new drug discovery and development. mark for My Articles similar articles
Chemistry World
December 1, 2010
Mike Brown
Glasgow IP giveaway The University of Glasgow is giving away its intellectual property for free in a move designed to maximize dissemination of knowledge and increase commercial collaboration. mark for My Articles similar articles
Pharmaceutical Executive
December 1, 2010
Zhu Shen
China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2009
Stan Bernard
Pharma vs. Pharma The most successful pharmaceutical companies will be those that can transform as the industry itself transforms. mark for My Articles similar articles
Bio-IT World
October 2006
Eric K. Neumann
The Advantages of a Drug Safety Commons Once a Drug Safety Commons has been established, a variety of derivative applications will be developed that can access as well as update the information in organized ways and used by industry researchers internally. mark for My Articles similar articles
CIO
August 28, 2009
Howell & Perera
How to Protect Your Legal Rights When Sharing IT Services To get the benefits from shared services, you need to address the risks to your company's intellectual property. mark for My Articles similar articles
Knowledge@Wharton Encouraging the Development of Drugs for Poor, not Just Rich, Nations The current system rewards research into diseases that afflict rich countries, but creating new medicines for the rest of the world and finding ways to pay for them will demand new partnerships, according to panelists at the recent conference "Pharmaceutical Innovation in a Global Economy." mark for My Articles similar articles
HBS Working Knowledge
November 13, 2006
Sean Silverthorne
Science Business: What Happened to Biotech? The biotech industry has underperformed expectations, caught in the conflicting objectives and requirements between science and business. mark for My Articles similar articles
ONLINE
November 2001
Peter Vanderheyden
Divide-and-Conquer Patent Research A revolutionary strategy to optimize your time and increase your influence... mark for My Articles similar articles
Managed Care
February 2002
Ira Studin
Reframing the Pharmaceutical Manufacturer/Health Plan Relationship in Managed Care It is suggested that health plans address "total cost-of-care savings" in their budget process, and the pharmaceutical manufacturers establish a "consultative service function" in their managed care divisions... mark for My Articles similar articles
The Motley Fool
June 29, 2006
Dan Caplinger
Starting a Small Business: Partnerships Establishing your business as a partnership offers flexibility but potential liability. mark for My Articles similar articles
Financial Advisor
March 2005
David L. Lawrence
Merging Options Five steps may help you avoid pitfalls and make your financial advisory practice merger a success. mark for My Articles similar articles
Chemistry World
July 10, 2015
Angeli Mehta
Business unable to access knowledge locked up in universities A bewildering array of organizations and schemes to support collaborative research between businesses and universities in the UK is leading to frustration and confusion, and needs to be simplified. mark for My Articles similar articles
Bio-IT World
June 17, 2004
Stephanie McRae
Expatriate Your Patents Intellectual property rights, especially patents, are often the principal source of value and revenue for biotechnology companies. You can save a boatload of tax money shipping your IP rights overseas. mark for My Articles similar articles
Chemistry World
November 1, 2011
Sarah Houlton
A Shot in the Arm for Drugs for Neglected Diseases A new consortium of public and private sector partners has been launched by the World Intellectual Property Organization. Its aim is to share intellectual property that may help find drugs for malaria, tuberculosis and other neglected tropical diseases. mark for My Articles similar articles
IndustryWeek
May 18, 2011
How to Build a Better Supplier Partnership Don't ignore the key concepts of trust, time and mutual benefits. mark for My Articles similar articles
Commercial Investment Real Estate
Jul/Aug 2003
John Mangham
Partnerships Can Use These Methods to Protect 1031 Gains Property owners wishing to dispose of appreciated assets often use Internal Revenue Code Section 1031 exchanges to defer capital gains taxes. However, partnerships wishing to execute exchanges face unique challenges, particularly when individuals in the partnership have diverging investment goals or want to cash out. mark for My Articles similar articles
Chemistry World
July 15, 2014
Emma Stoye
Public--private research partnerships to tackle Europe's big problems The European Union will invest euro 7.3 billion in seven newly launched public -- private partnerships as part of its Horizon2020 research funding program. mark for My Articles similar articles
InternetNews
May 4, 2005
Michael Singer
Microsoft Expands IP Program to SMBs Entrepreneurs can choose from 20 technologies from Microsoft's R&D portfolio. Microsoft Intellectual Property Ventures complements its policy of licensing to larger corporations and governments. mark for My Articles similar articles
Entrepreneur
March 2006
Marc Diener
Two's Company Before you start negotiating a business partnership, take these three key steps. mark for My Articles similar articles
Registered Rep.
October 30, 2014
Philip Palaveev
To Ensemble or Not To Ensemble Thousands of advisors are negotiating the combination of their practices with others in order to create scale, leverage each other's skills, gain resources, and tackle succession. mark for My Articles similar articles